NCT06035250Recruiting
AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
Deep Learning-Based Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
Source: ClinicalTrials.gov · Last updated 28 Sept 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study seeks to develop a deep-learning-based intelligent predictive model for the efficacy of neoadjuvant chemotherapy in gastric cancer patients. By utilizing the patients' CT imaging data, biopsy pathology images, and clinical information, the intelligent model will predict the post-neoadjuvant chemotherapy efficacy and prognosis, offering assistance in personalized treatment decisions for gastric cancer patients.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 13 Aug 2023
- Start date
- 10 Sept 2023
- Primary completion date
- 31 Aug 2024
- Lead sponsor
- Chinese Academy of Sciences
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT06035250
What you commit to
- Study type: Observational
- Planned participants: 200
- From 10 Sept 2023 to the primary completion date, 31 Aug 2024
- 22 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients diagnosed with other concurrent tumors.
Other
- Patients whose CT or pathology images are unclear, making lesion assessment infeasible;
Who the study is looking for
- Age 18 years or older;
- Pathologically diagnosed with advanced gastric cancer in accordance with the American AJCC's TNM staging standards;
- Have not undergone any systematic anti-cancer treatments before neoadjuvant chemotherapy and have not had surgery for local progression or distant metastasis;
- Received standard neoadjuvant chemotherapy as recommended by the clinical guidelines, and have documented treatment details;
- CT imaging and biopsy pathology images strictly taken within one month prior to starting neoadjuvant treatment;
- Patients possess comprehensive preoperative clinical information and post-operative TRG grading.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (22)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Peking University Cancer Hospital & Institute Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences Coordinator of this site? Confirm its status | Beijing | China | Not yet recruiting |
| Peking Union Medical College Hospital Coordinator of this site? Confirm its status | Beijing | China | Not yet recruiting |
| Peking University People's Hospital Coordinator of this site? Confirm its status | Beijing | China | Not yet recruiting |
| Xiangya Hospital of Central South University Coordinator of this site? Confirm its status | Changsha | China | Not yet recruiting |
| Fujian Cancer Hospital Coordinator of this site? Confirm its status | Fuzhou | China | Not yet recruiting |
| Fujian Medical University Union Hospital Coordinator of this site? Confirm its status | Fuzhou | China | Recruiting |
| First Affiliated Hospital, Sun Yat-Sen University Coordinator of this site? Confirm its status | Guangzhou | China | Not yet recruiting |
| Affiliated Cancer Hospital & Institute of Guangzhou Medical University Coordinator of this site? Confirm its status | Guangzhou | China | Not yet recruiting |
| Sixth Affiliated Hospital, Sun Yat-sen University Coordinator of this site? Confirm its status | Guangzhou | China | Recruiting |
| Nanfang Hospital of Southern Medical University Coordinator of this site? Confirm its status | Guangzhou | China | Not yet recruiting |
| Yunnan Cancer Hospital Coordinator of this site? Confirm its status | Kunming | China | Recruiting |
| Cancer Hospital of Guangxi Medical University Coordinator of this site? Confirm its status | Nanning | China | Not yet recruiting |
| The Affiliated Hospital of Qingdao University Coordinator of this site? Confirm its status | Qingdao | China | Not yet recruiting |
| Ruijin hospital Coordinator of this site? Confirm its status | Shanghai | China | Not yet recruiting |
| First Hospital of China Medical University Coordinator of this site? Confirm its status | Shenyang | China | Not yet recruiting |
| The First Affiliated Hospital of Soochow University Coordinator of this site? Confirm its status | Suzhou | China | Not yet recruiting |
| Tianjin Medical University Cancer Institute and Hospital Coordinator of this site? Confirm its status | Tianjin | China | Not yet recruiting |
| The First Affiliated Hospital of Zhengzhou University Coordinator of this site? Confirm its status | Zhengzhou | China | Recruiting |
| Henan Cancer Hospital Coordinator of this site? Confirm its status | Zhengzhou | China | Recruiting |
| Zhenjiang First People's Hospital Coordinator of this site? Confirm its status | Zhenjiang | China | Recruiting |
| San Raffaele University Hospital, Italy Coordinator of this site? Confirm its status | Milan | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.